HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

TNK-tissue plasminogen activator

a genetically-engineered variant of tissue plasminogen activator with amino acid substitutions at Thr(103) by Asn, Asn(117) by glutamine, and 4 amino acids (Lys, His, Arg, Arg) replaced by 4 alanines at the 3rd site
Also Known As:
TNK-TPA
Networked: 26 relevant articles (8 outcomes, 18 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Berioli, S: 2 articles (12/2001 - 01/2001)
2. Fox, N L: 2 articles (12/2001 - 01/2001)
3. Gibson, C M: 2 articles (09/2001 - 01/2001)
4. Jain, R K: 1 article (07/2013)
5. Sathyamurthy, I: 1 article (07/2013)
6. Nair, T: 1 article (07/2013)
7. Jadhav, U: 1 article (07/2013)
8. Hiremath, J S: 1 article (07/2013)
9. Kumbla, D: 1 article (07/2013)
10. Iyengar, S S: 1 article (07/2013)

Related Diseases

1. Myocardial Infarction
2. Stroke (Strokes)
3. Body Weight (Weight, Body)
4. Ischemia
5. Embolism (Embolus)

Related Drugs and Biologics

1. tenecteplase
2. Fibrin
3. Tissue Plasminogen Activator (Alteplase)
4. Enoxaparin (Lovenox)
5. Heparin (Liquaemin)
6. disufenton sodium (NXY 059)
7. abciximab (ReoPro)
8. TNK-tissue plasminogen activator
9. MB Form Creatine Kinase
10. Troponin I

Related Therapies and Procedures

1. Catheters
2. Thrombolytic Therapy
3. Medication Errors (Medication Error)
4. Aftercare (After-Treatment)